arrow
A

Antonio Salas

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
H指数:76
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Bayesian Re-analysis of the GALFLU Trial of High-Dose vs Standard-Dose Influenza Vaccine Against Hospitalization Outcomes

高剂量与标准剂量流感疫苗对住院结局影响的GALFLU试验贝叶斯再分析

2026-08-030
OAAI
Whole-Genome Sequencing in Galicia Reveals Male-Biased Pre-Islamic North African Ancestry, Subtle Population Structure, and Microgeographic Patterns of Disease Risk

全基因组测序在加利西亚的发现:揭示了男性偏向的伊斯兰教前北非祖先、微妙的人口结构以及疾病风险的微观地理模式

2025-12-130
OAAI
Music elicits different gene expression responses in the buccal cavity of age-related cognitive disorders patients and healthy controls

音乐在年龄相关性认知障碍患者和健康对照组的口腔腔中诱导不同的基因表达反应。

2025-09-260
OAAI
Genetic Determinants of the Complement and Coagulation Pathways in Invasive Meningococcal Disease

侵袭性脑膜炎球菌病中补体和凝血通路的遗传决定因素

2025-09-210
OAAI
Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications

Fonseca KL,Lozano JJ,Despuig A,Habgood-Coote D,Sidorova J,Aznar D,等。解析人类结核病病灶的转录组及其临床意义。Nat Commun. (2025) 16:5028. doi: 10.1038/s41467-025-60255-w。

2025-05-300
OAAI
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL study

尼瑞西玛(nirsevimab)在加利西亚(Galicia, Spain)婴儿中的呼吸道合胞病毒相关下呼吸道感染住院情况:NIRSE-GAL研究

2025-05-020
OA
Synergic Integration of the miRNome, Machine Learning and Bioinformatics for the Identification of Potential Disease-Modifying Agents in Obstructive Sleep Apnea

协同整合miRNome、机器学习和生物信息学,以识别阻塞性睡眠呼吸暂停中的潜在疾病修饰剂

2024-12-050
PRE
Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis Syndrome

全外显子组测序鉴定食物蛋白诱导的小肠结肠炎综合征中上皮和免疫功能障碍相关的生物标志物

2024-09-300
OAAI
Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein-Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study
2024-09-011
OAAI
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
2024-05-133
OAAI
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
2024-05-038
OA
Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia
2024-05-010
OAAI